CEO received an award of 149K AMPH derivative securities | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Mar 9, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Mar 11, 2026
CEOIndirect holdingGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
0000889740-26-000005
Filed / recordedMar 11, 2026, 9:58 PM UTC Added to OQROOct 6, 2026, 9:54 PM UTC Data qualityVerified: identifiers matched exactly IssuerAmphastar Pharmaceuticals, Inc. Reporting personJack Y. Zhang RelationshipDirector, Officer, 10% owner Officer titleCEO & CHIEF SCIENTIFIC OFFICER SecurityEmployee Stock Option (right to buy) TableDerivative (Table II) Transaction dateMar 9, 2026 Acquired / disposedAcquired (A) Shares owned after149,472 Ownership formIndirect — See footnote Footnotes from the filing
- The shares subject to the option vest in four equal annual installments beginning on March 9, 2027.
- The securities are held of record by Mary Z. Luo. The reporting persons are husband and wife.
Around the same time
Traded Mar 15 · filed 3 days later
Routine share withholding; mechanical by default.
Traded Mar 15 · filed 2 days later
Routine share withholding; mechanical by default.
Traded Mar 15 · filed 2 days later
Routine share withholding; mechanical by default.